Answers are grounded in this paper and cite their sources.
Shows reduced correlation between partial thromboplastin time and chromogenic heparin assays during concurrent warfarin therapy, highlighting benefits of chromogenic monitoring.
Heparin therapy was evaluated by simultaneous determinations of the activated partial thromboplastin time (APTT), and plasma heparin levels by chromogenic assay. These tests showed good correlation (r = 0.73) in patients on heparin alone. However, in the presence of concurrent warfarin administration, r fell to 0.37, reflecting an additional warfarin effect upon the APTT. Furthermore, the studies confirmed the increased heparin requirement in patients with pulmonary embolization.
No takes yet. Share an insight, caveat, or question.
Chong et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: